Free Trial

InMode Q2 2024 Earnings Report

InMode logo
$16.79 +0.22 (+1.33%)
As of 01/17/2025 04:00 PM Eastern

InMode EPS Results

Actual EPS
$0.34
Consensus EPS
$0.38
Beat/Miss
Missed by -$0.04
One Year Ago EPS
$0.65

InMode Revenue Results

Actual Revenue
$102.60 million
Expected Revenue
$104.81 million
Beat/Miss
Missed by -$2.21 million
YoY Revenue Growth
-24.60%

InMode Announcement Details

Quarter
Q2 2024
Time
Before Market Opens

INMD Upcoming Earnings

InMode will be holding an earnings conference call on Tuesday, February 4 at 8:30 AM Eastern. Interested parties can register for or listen to the call or dial in at 412-317-0088 using passcode "4023671".

Conference Call Resources

InMode Earnings Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More InMode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like InMode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on InMode and other key companies, straight to your email.

About InMode

InMode (NASDAQ:INMD) designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

View InMode Profile

More Earnings Resources from MarketBeat